ACTIVE

SENNE PHARMA

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

17 k €

+84.2% YoY

Gross margin

126,2 k €

-24.1% YoY

Equity

197,6 k €

+9.4% YoY

Workforce

1,5 ETP

-6.3% YoY

What does SENNE PHARMA do?

SENNE PHARMA is a Private limited company incorporated in 2004. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Soignies. It employs on average 1,5 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0866.380.739

Incorporation

15/07/2004

Legal form

Private limited company

Registered office

Rue de la Station 49
7060 Soignies · WallonieSee on map

Contributed capital

18 600,00 €

Latest accounts

31/12/2025

Average workforce

1,5 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (2)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	126,2 k €	-24.1%	166,3 k €	-4.1%	173,4 k €	+3.9%	166,8 k €	+9.1%	152,9 k €	-21.2%	194 k €	+67.4%	115,9 k €	-21.8%	148,1 k €	+30.4%	113,6 k €	-11.1%	127,8 k €	+2.4%	124,8 k €	+0.2%	124,6 k €	+4.5%	119,2 k €	+9.6%	108,7 k €	+23.0%	88,4 k €	+11.1%	79,5 k €	+77.8%	44,7 k €	+5.0%	42,6 k €	-19.7%	53,1 k €	+11.3%	47,7 k €
EBITDA	77,3 k €	+16.0%	66,7 k €	-30.2%	95,5 k €	+44.8%	65,9 k €	+11.4%	59,2 k €	-54.2%	129,3 k €	+111%	61,2 k €	-39.5%	101,2 k €	+50.9%	67 k €	-22.7%	86,7 k €	+9.2%	79,4 k €	-6.5%	84,9 k €	+2.5%	82,9 k €	+6.0%	78,1 k €	-7.2%	84,2 k €	+11.7%	75,4 k €	+75.8%	42,9 k €	+3.6%	41,4 k €	-20.3%	51,9 k €	+42.8%	36,4 k €
Operating result	35,4 k €	+47.1%	24,1 k €	-54.4%	52,8 k €	+147%	21,4 k €	+69.2%	12,6 k €	-84.6%	82,2 k €	+35924%	-229,4 €	-101%	36,7 k €	+13.8%	32,2 k €	-39.5%	53,3 k €	+16.8%	45,6 k €	-14.1%	53,1 k €	+12.3%	47,2 k €	+19.6%	39,5 k €	-17.2%	47,7 k €	+21.7%	39,2 k €	+127%	17,3 k €	+15.9%	14,9 k €	-41.1%	25,3 k €	+113%	11,9 k €
Net result	17 k €	+84.2%	9,2 k €	-69.1%	29,9 k €	+397%	6 k €	+7457%	-81,9 €	-100%	47,6 k €	+393%	-16,2 k €	-169%	23,5 k €	+84.2%	12,8 k €	-50.6%	25,8 k €	+25.9%	20,5 k €	-20.4%	25,8 k €	+15.2%	22,4 k €	+41.9%	15,8 k €	-26.0%	21,3 k €	+65.8%	12,9 k €	+494%	-3,3 k €	-21.0%	-2,7 k €	-217%	2,3 k €	+162%	-3,8 k €
Balance sheet
Equity	197,6 k €	+9.4%	180,6 k €	+5.4%	171,4 k €	-0.9%	173 k €	-3.7%	179,7 k €	-0.0%	179,8 k €	+13.8%	158 k €	-9.3%	174,2 k €	+15.6%	150,7 k €	+9.3%	137,9 k €	+23.0%	112,1 k €	+22.4%	91,6 k €	+39.2%	65,8 k €	+51.6%	43,4 k €	+57.1%	27,6 k €	+338%	6,3 k €	+196%	-6,6 k €	-99.1%	-3,3 k €	-452%	-596 €	+79.5%	-2,9 k €
Total assets	617,6 k €	-6.2%	658,5 k €	-4.8%	691,5 k €	+0.8%	685,8 k €	-4.7%	719,8 k €	-5.8%	764,3 k €	+2.9%	742,5 k €	-8.6%	812,3 k €	+72.6%	470,5 k €	-2.8%	484,3 k €	+2.5%	472,3 k €	+9.0%	433,2 k €	-3.0%	446,3 k €	-3.8%	464 k €	-5.7%	492 k €	-4.8%	516,7 k €	-2.8%	531,7 k €	+46.9%	361,9 k €	-1.0%	365,7 k €	-7.6%	395,5 k €
Cash	131,2 k €	+23.1%	106,6 k €	-14.2%	124,2 k €	+14.6%	108,4 k €	-8.7%	118,7 k €	+49.5%	79,4 k €	-12.4%	90,6 k €	-35.6%	140,7 k €	+112%	66,3 k €	+7.4%	61,7 k €	+23.5%	50 k €	+101%	24,9 k €	-6.2%	26,5 k €	-4.4%	27,7 k €	+3.5%	26,8 k €	+2.6%	26,1 k €	-11.5%	29,5 k €	+557%	4,5 k €	+117%	2,1 k €	-67.7%	6,4 k €
Debts	416,5 k €	-11.6%	471 k €	-8.8%	516,3 k €	+1.5%	508,8 k €	-5.4%	537,6 k €	-7.6%	582 k €	+0.0%	582 k €	-8.5%	635,9 k €	+99.9%	318 k €	-7.7%	344,4 k €	-3.8%	358,1 k €	+5.4%	339,8 k €	-10.2%	378,5 k €	-9.9%	420,3 k €	-9.4%	464 k €	-8.8%	509 k €	-5.2%	537,1 k €	+47.4%	364,5 k €	-0.5%	366,2 k €	-8.0%	398,2 k €
Other
Workforce	1,5 ETP	-6.3%	1,6 ETP	-15.8%	1,9 ETP	-5.0%	2,0 ETP	0.0%	2,0 ETP	+42.9%	1,4 ETP	+27.3%	1,1 ETP	+10.0%	1,0 ETP	+25.0%	0,8 ETP	-11.1%	0,9 ETP	-10.0%	1,0 ETP	+11.1%	0,9 ETP	0.0%	0,9 ETP	+50.0%	0,6 ETP	+500%	0,1 ETP	0.0%	0,1 ETP	-90.0%	1,0 ETP		–		–		0,1 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 4 ended

Active mandates

Catherine USVALD

Director

Active

Ended mandates

Catherine USVALD

Manager

Ended

Françoise DELAISSE

Manager

Ended

Laurence DENBLYDEN

Associate

Ended

Thierry SIMILLION

Associate

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	31/08/2026	26/08/2025	29/08/2024	29/08/2023	26/08/2022	31/08/2021
General meeting	10/06/2026	11/06/2025	12/06/2024	14/06/2023	08/06/2022	09/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	10/06/2026	31/08/2026	French	PDF
Abridged model	31/12/2024	11/06/2025	26/08/2025	French	PDF
Abridged model	31/12/2023	12/06/2024	29/08/2024	French	PDF
Abridged model	31/12/2022	14/06/2023	29/08/2023	French	PDF
Abridged model	31/12/2021	08/06/2022	26/08/2022	French	PDF
Abridged model	31/12/2020	09/06/2021	31/08/2021	French	PDF
Abridged model	31/12/2019	10/06/2020	30/10/2020	French	PDF
Abridged model	31/12/2018	12/06/2019	29/08/2019	French	PDF
Abridged model	31/12/2017	13/06/2018	29/08/2018	French	PDF
Abridged model	31/12/2016	14/06/2017	30/08/2017	French	PDF
Abridged model	31/12/2015	08/06/2016	31/08/2016	French	PDF
Abridged model	31/12/2014	10/06/2015	12/08/2015	French	PDF
Abridged model	31/12/2013	11/06/2014	30/07/2014	French	PDF
Abridged model	31/12/2012	12/06/2013	29/07/2013	French	PDF
Abridged model	31/12/2011	13/06/2012	31/07/2012	French	PDF
Abridged model	31/12/2010	08/06/2011	27/07/2011	French	PDF
Abridged model	31/12/2009	09/06/2010	28/07/2010	French	PDF
Abridged model	31/12/2008	10/06/2009	22/06/2009	French	PDF
Abridged model	31/12/2007	11/06/2008	16/06/2008	French	PDF
Abridged model	31/12/2006	13/06/2007	03/07/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 4 ended

Active mandates

Catherine USVALD

Director

Active

Ended mandates

Catherine USVALD

Manager

Ended

Françoise DELAISSE

Manager

Ended

Laurence DENBLYDEN

Associate

Ended

Thierry SIMILLION

Associate

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates28/11/2023
MODIFICATION FORME JURIDIQUE - DIVERS - DEMISSIONS, NOMINATIONS
PDF
Mandates06/05/2011
DENOMINATION - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates16/10/2009
DEMISSIONS, NOMINATIONS
PDF
Mandates14/10/2009
DEMISSIONS, NOMINATIONS
PDF
Other26/07/2004
RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202517 k €↑
2024
Annual accounts 20249,2 k €↓
2023
Annual accounts 202329,9 k €↑
2022
Annual accounts 20226 k €↑
2021
Annual accounts 2021-81,9 €↓
2020
Annual accounts 202047,6 k €↑
2019
Annual accounts 2019-16,2 k €↓
2018
Annual accounts 201823,5 k €↑
2017
Annual accounts 201712,8 k €↓
2016
Annual accounts 201625,8 k €↑
2015
Annual accounts 201520,5 k €↓
2014
Annual accounts 201425,8 k €↑
2013
Annual accounts 201322,4 k €↑
2012
Annual accounts 201215,8 k €↓
2011
Annual accounts 201121,3 k €↑
2010
Annual accounts 201012,9 k €↑
2009
Annual accounts 2009-3,3 k €↓
2008
Annual accounts 2008-2,7 k €↓
2007
Annual accounts 20072,3 k €↑
2006
Annual accounts 2006-3,8 k €
15/07/2004
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

SENNE PHARMA

Overview

What does SENNE PHARMA do?

Trend over 20 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline